ConexiantPediatric Allergic Rhinitis: When Meds Fall Short

⚠️ Small Study / Early Comparative Evidence
A prospective cohort study compared inferior turbinate reduction with continued medical therapy in children with allergic rhinitis who remained symptomatic despite standard pharmacologic treatment, examining short‑term symptom relief, nasal obstruction, and sleep‑related quality of life.

Key Clinical Considerations

• Children in the study had persistent allergic rhinitis symptoms despite at least three months of intranasal corticosteroids and oral antihistamines.
• Inferior turbinate reduction was associated with greater short‑term improvements in sinonasal symptoms and sleep‑related quality of life.
• Outcomes were based primarily on patient‑reported measures and short‑term endoscopic findings.

Clinical Practice Impact

• Suggests a potential role for surgical intervention in carefully selected pediatric patients with refractory disease.
• Highlights the need for shared decision‑making, particularly when symptoms affect sleep and daily functioning.
• Reinforces that evidence remains preliminary, with limited follow‑up and sample size.

More in ENT